The Ritedose team shepherds your product from early-phase clinicals to commercial scale in enviable time – an average 18 to 20 days from formulation to shipment. From development engineers and chemists to regulatory and packaging experts, our specialists deploy rigorous environmental controls to deliver sterile manufacturing and eliminate problems before they occur.
That’s why our clients come back year after year, product after product. Because we know every day you aren’t on the market is a lost opportunity.
With an annual capacity of 2.1+ billion units, Ritedose is the largest sterile CDMO in the U.S. focused on advanced BFS technology. For 27 years we’ve honed this delivery system to drive the fastest, most cost-effective sterile unit dose packaging anywhere.
BFS is an advanced aseptic manufacturing process where the container is formed, filled and sealed in one continuous automated system, assuring consistent doses and the highest degree of sterility. Preferred for inhalation and ophthalmic products – two specialty markets served by Ritedose – this packaging technology is ideal for high-speed production and cost effective when compared to glass.
Pioneers in aseptic production of sterile, single-dose medication